X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ELDER PHARMA - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ELDER PHARMA PFIZER/
ELDER PHARMA
 
P/E (TTM) x 32.9 -0.2 - View Chart
P/BV x 4.9 0.1 4,858.7% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 PFIZER   ELDER PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-17
ELDER PHARMA
Jun-14
PFIZER/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs2,055380 540.8%   
Low Rs1,651188 878.2%   
Sales per share (Unadj.) Rs429.8491.2 87.5%  
Earnings per share (Unadj.) Rs73.6-3.2 -2,313.7%  
Cash flow per share (Unadj.) Rs87.414.4 606.4%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs528.7376.5 140.4%  
Shares outstanding (eoy) m45.7520.54 222.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.30.6 745.7%   
Avg P/E ratio x25.2-89.3 -28.2%  
P/CF ratio (eoy) x21.219.7 107.6%  
Price / Book Value ratio x3.50.8 464.6%  
Dividend payout %27.20-   
Avg Mkt Cap Rs m84,7775,833 1,453.3%   
No. of employees `0002.8NA-   
Total wages/salary Rs m3,0392,179 139.5%   
Avg. sales/employee Rs Th6,925.9NM-  
Avg. wages/employee Rs Th1,070.4NM-  
Avg. net profit/employee Rs Th1,186.3NM-  
INCOME DATA
Net Sales Rs m19,66310,089 194.9%  
Other income Rs m1,012257 394.2%   
Total revenues Rs m20,67410,346 199.8%   
Gross profit Rs m3,491-792 -440.9%  
Depreciation Rs m629361 174.2%   
Interest Rs m102,756 0.3%   
Profit before tax Rs m3,864-3,653 -105.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1,3043,713 35.1%   
Tax Rs m1,801125 1,438.8%   
Profit after tax Rs m3,368-65 -5,153.5%  
Gross profit margin %17.8-7.8 -226.2%  
Effective tax rate %46.6-3.4 -1,360.2%   
Net profit margin %17.1-0.6 -2,644.3%  
BALANCE SHEET DATA
Current assets Rs m20,7899,240 225.0%   
Current liabilities Rs m7,8709,998 78.7%   
Net working cap to sales %65.7-7.5 -874.9%  
Current ratio x2.60.9 285.8%  
Inventory Days Days6046 129.0%  
Debtors Days Days2260 37.4%  
Net fixed assets Rs m9,17510,124 90.6%   
Share capital Rs m458206 222.4%   
"Free" reserves Rs m23,7315,582 425.1%   
Net worth Rs m24,1897,734 312.8%   
Long term debt Rs m254,889 0.5%   
Total assets Rs m32,70622,882 142.9%  
Interest coverage x403.5-0.3 -124,042.7%   
Debt to equity ratio x00.6 0.2%  
Sales to assets ratio x0.60.4 136.3%   
Return on assets %10.311.8 87.8%  
Return on equity %13.9-0.8 -1,647.6%  
Return on capital %21.422.3 95.9%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m63307 20.5%   
Fx outflow Rs m4,067125 3,245.6%   
Net fx Rs m-4,004181 -2,208.4%   
CASH FLOW
From Operations Rs m3,28811,754 28.0%  
From Investments Rs m-2,496-561 445.4%  
From Financial Activity Rs m-826-6,762 12.2%  
Net Cashflow Rs m-354,432 -0.8%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 7.5 100.0%  
FIIs % 4.9 16.8 29.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 36.1 65.7%  
Shareholders   85,207 16,479 517.1%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STERLING BIOTECH  SANOFI INDIA  ALEMBIC PHARMA  ORCHID PHARMA LTD  NOVARTIS  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 22, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS